Maximus, Inc. (NYSE:MMS) Plans $0.30 Quarterly Dividend

Maximus, Inc. (NYSE:MMS) announced a quarterly dividend on Monday, April 7th, RTT News reports. Stockholders of record on Thursday, May 15th will be paid a dividend of 0.30 per share by the health services provider on Saturday, May 31st. This represents a $1.20 annualized dividend and a dividend yield of 1.75%.

Maximus has increased its dividend payment by an average of 2.3% per year over the last three years. Maximus has a dividend payout ratio of 18.9% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Maximus to earn $5.76 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 20.8%.

Maximus Stock Down 2.4 %

MMS stock opened at $68.61 on Monday. The stock’s 50 day simple moving average is $69.16 and its 200 day simple moving average is $77.12. The company has a market cap of $3.88 billion, a P/E ratio of 14.76 and a beta of 0.68. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. Maximus has a fifty-two week low of $63.77 and a fifty-two week high of $93.97.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, research analysts expect that Maximus will post 6.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on MMS shares. StockNews.com downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a report on Thursday, January 2nd.

Insider Buying and Selling at Maximus

In other news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the sale, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.